Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VENTURI: Trimbow vs Trelegy in Moderate to Severe Asthma
NCT07282886Phase 2Recruiting
- Sponsor
- University of Alabama at Birmingham
- Start
- Mar 2026
- Primary completion
- Dec 2028
- Modality
- Inhalation Devices, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of beclometasone dipropionate/formoterol fumarate/glycopyrronium in asthma, sponsored by University of Alabama at Birmingham. Started Mar 2026; status: recruiting.
02
Drugs
beclometasone dipropionate/formoterol fumarate/glycopyrronium
03
Conditions
asthma
Beyond the preview
Go deeper on NCT07282886.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07282886.